Financials
- Market Capitalization 431.21 M
- Employee 104
- Founded 2015
- CEO N/A
- Website www.c4therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00BV2Y9B7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.5
ratio cours/chiffre d'affaires
4.4
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3012 | SLN Silence Therapeutics Plc - American Depository Share | 9.36 USD | +0.75% | -12.77% | +37.85% | +48.10% | 442.12 M USD | ||
| 3016 | EVMN Evommune, Inc. Common Stock | 12.22 USD | +0.91% | -9.95% | -38.96% | -29.45% | 440.14 M USD | ||
| 3037 | ASMB Assembly Biosciences, Inc. - Common Stock | 26.86 USD | -0.37% | -6.28% | +13.48% | -8.72% | 426.88 M USD | ||
| 3046 | TENX Tenax Therapeutics, Inc. - Common Stock | 15.96 USD | -0.13% | -0.56% | +37.00% | +111.39% | 423.34 M USD |